Inflammatory Bowel Disease Series: Inflammatory Bowel Disease in Special Populations: The Elderly, Obese and LGBTQ Patient

Host: Darryl S. Chutka, M.D. Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S. This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Konstantinos A. Papadakis, M.D. Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance?  Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I’ll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It’s usually suspected from the patient’s clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn’t known but it can be associated with several medications. Although it’s not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn’s Disease? Who’s at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured?  These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: Edward V. Loftus JR, M.D. Inflammatory Bowel Disease is somewhat of an umbrella term for a group of chronic inflammatory conditions of the GI tract. The most common types include ulcerative colitis and Crohn’s Disease. While there are similarities between the two, there are also differences. For many individuals with inflammatory bowel disease, it’s only a mild illness. Unfortunately for some, it can lead to severe disability and potentially life-threatening complications. What are the similarities and differences between ulcerative colitis and Crohn’s? When should we suspect a patient has an inflammatory bowel disease? What’s the best way to establish a diagnosis and finally, what treatment options do we have? These are just some of the questions I’ll be asking my guest, Edward V. Loftus JR, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Its Treatment”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S. An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex.  The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease   Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts   

Host: Denise M. Dupras, M.D., Ph.D. Guest: Melissa Davis, Ph.D., Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine In this insightful episode, Dr. Melissa Davis delves into the profound influence of genetic ancestry on health outcomes and disparities. Her pioneering work in disparities genomics sheds light on how biological determinants intersect with systemic marginalization to exacerbate cancer health disparities. Dr. Davis discusses groundbreaking research linking ancestry to tumor biology, particularly in breast, prostate, and gynecologic cancers. This episode offers a compelling narrative on the evolving immune system's role in tumor aggressiveness and resistance to standard care, offering a new lens for addressing health inequities. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guests: Jesse D. Bracamonte, D.O., Casey Martinez, Kiyan Heybati If you’re a physician, there are several events during your medical journey that you’ll always remember, receiving your letter of acceptance for medical school, medical school graduation and Match Day. For those of you who aren’t physicians, Match Day is a very exciting day for medical students. It represents the day students learn where they’ll be doing their residency training. It’s a complicated process that uses an algorithm to match students and residency positions. But what happens if a student doesn’t match with a residency program, what are their options? What do residency programs consider when ranking the numerous student candidates?  What are some common mistakes students make during the match process and how can students maximize their chances of matching with one of their top residency choices? These are questions I’ll be asking my guests, Jesse D. Bracamonte, D.O., a family physician and Associate Dean of Student Affairs at the Arizona campus of the Mayo Clinic, as well as Casey Martinez and Kiyan Heybati, both senior medical students from the Mayo Clinic Alix School of Medicine. Our topic of discussion for this podcast will be “Navigating the Match: What Every Medical Student Should Know”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Denise M. Dupras, M.D., Ph.D. Guest: John R. Giudicessi, M.D., Ph.D. Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi’s insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: John W. Wilson, M.D. Tuberculosis remains a significant health concern. Globally, in 2023, an estimated 10 million individuals developed active tuberculosis and over one million died of the disease. In the U.S., just under 10, 000 individuals in the U.S. were diagnosed with TB, representing an increase over 2022. While tuberculosis remains a treatable disease, it’s important to suspect and recognize those who may have it. A class 5 tuberculosis case is part of a TB classification system and refers to a suspected tuberculosis infection that requires further investigation. Symptoms may or may not be present and these patients may have an active TB case that could be contagious. This podcast is about class 5 tuberculosis cases, and my guest is infectious disease specialist, John W. Wilson, M.D., from the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts